0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Integrase Inhibitors Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-24Y10157
Home | Market Reports | Health| Reproductive Health
Global Integrase Inhibitors Market Research Report 2022
BUY CHAPTERS

Global Integrase Inhibitors Market Research Report 2025

Code: QYRE-Auto-24Y10157
Report
March 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Integrase Inhibitors Market Size

The global market for Integrase Inhibitors was valued at US$ 440 million in the year 2024 and is projected to reach a revised size of US$ 720 million by 2031, growing at a CAGR of 7.4% during the forecast period.

Integrase Inhibitors Market

Integrase Inhibitors Market

Integrase inhibitors (INIs) are the most new class of antiretroviral medications to be approved to treat HIV infection. They are quickly becoming standard treatments for both HIV naive and substantially pre-treated patients.
Integrase inhibitors (INIs) are the most new class of antiretroviral medications to be approved to treat HIV infection. They are quickly becoming standard treatments for both HIV naive and substantially pre-treated patients.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Integrase Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Integrase Inhibitors.
The Integrase Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Integrase Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Integrase Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Integrase Inhibitors Market Report

Report Metric Details
Report Name Integrase Inhibitors Market
Accounted market size in year US$ 440 million
Forecasted market size in 2031 US$ 720 million
CAGR 7.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Clinic
  • Hospital
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GlaxoSmithKline, Hetero Drugs, Mylan, Aurobindo Pharma, Cipla, Laurus Labs, Gilead Sciences, Micro Labs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Integrase Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Integrase Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Integrase Inhibitors Market growing?

Ans: The Integrase Inhibitors Market witnessing a CAGR of 7.4% during the forecast period 2025-2031.

What is the Integrase Inhibitors Market size in 2031?

Ans: The Integrase Inhibitors Market size in 2031 will be US$ 720 million.

Who are the main players in the Integrase Inhibitors Market report?

Ans: The main players in the Integrase Inhibitors Market are Merck, GlaxoSmithKline, Hetero Drugs, Mylan, Aurobindo Pharma, Cipla, Laurus Labs, Gilead Sciences, Micro Labs

What are the Application segmentation covered in the Integrase Inhibitors Market report?

Ans: The Applications covered in the Integrase Inhibitors Market report are Clinic, Hospital

What are the Type segmentation covered in the Integrase Inhibitors Market report?

Ans: The Types covered in the Integrase Inhibitors Market report are Raltegravir, Dolutegravir, Elvitegravir, Bictegravir

Recommended Reports

Antiretroviral Markets

Combination HIV Drugs

Antiviral Therapeutics

1 Integrase Inhibitors Market Overview
1.1 Product Definition
1.2 Integrase Inhibitors by Type
1.2.1 Global Integrase Inhibitors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Raltegravir
1.2.3 Dolutegravir
1.2.4 Elvitegravir
1.2.5 Bictegravir
1.3 Integrase Inhibitors by Application
1.3.1 Global Integrase Inhibitors Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Integrase Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Integrase Inhibitors Revenue 2020-2031
1.4.2 Global Integrase Inhibitors Sales 2020-2031
1.4.3 Global Integrase Inhibitors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Integrase Inhibitors Market Competition by Manufacturers
2.1 Global Integrase Inhibitors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Integrase Inhibitors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Integrase Inhibitors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Integrase Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Integrase Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Integrase Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of Integrase Inhibitors, Date of Enter into This Industry
2.8 Global Integrase Inhibitors Market Competitive Situation and Trends
2.8.1 Global Integrase Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Integrase Inhibitors Players Market Share by Revenue
2.8.3 Global Integrase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Integrase Inhibitors Market Scenario by Region
3.1 Global Integrase Inhibitors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Integrase Inhibitors Sales by Region: 2020-2031
3.2.1 Global Integrase Inhibitors Sales by Region: 2020-2025
3.2.2 Global Integrase Inhibitors Sales by Region: 2026-2031
3.3 Global Integrase Inhibitors Revenue by Region: 2020-2031
3.3.1 Global Integrase Inhibitors Revenue by Region: 2020-2025
3.3.2 Global Integrase Inhibitors Revenue by Region: 2026-2031
3.4 North America Integrase Inhibitors Market Facts & Figures by Country
3.4.1 North America Integrase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Integrase Inhibitors Sales by Country (2020-2031)
3.4.3 North America Integrase Inhibitors Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Integrase Inhibitors Market Facts & Figures by Country
3.5.1 Europe Integrase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Integrase Inhibitors Sales by Country (2020-2031)
3.5.3 Europe Integrase Inhibitors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Integrase Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific Integrase Inhibitors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Integrase Inhibitors Sales by Region (2020-2031)
3.6.3 Asia Pacific Integrase Inhibitors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Integrase Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Integrase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Integrase Inhibitors Sales by Country (2020-2031)
3.7.3 Latin America Integrase Inhibitors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Integrase Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Integrase Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Integrase Inhibitors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Integrase Inhibitors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Integrase Inhibitors Sales by Type (2020-2031)
4.1.1 Global Integrase Inhibitors Sales by Type (2020-2025)
4.1.2 Global Integrase Inhibitors Sales by Type (2026-2031)
4.1.3 Global Integrase Inhibitors Sales Market Share by Type (2020-2031)
4.2 Global Integrase Inhibitors Revenue by Type (2020-2031)
4.2.1 Global Integrase Inhibitors Revenue by Type (2020-2025)
4.2.2 Global Integrase Inhibitors Revenue by Type (2026-2031)
4.2.3 Global Integrase Inhibitors Revenue Market Share by Type (2020-2031)
4.3 Global Integrase Inhibitors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Integrase Inhibitors Sales by Application (2020-2031)
5.1.1 Global Integrase Inhibitors Sales by Application (2020-2025)
5.1.2 Global Integrase Inhibitors Sales by Application (2026-2031)
5.1.3 Global Integrase Inhibitors Sales Market Share by Application (2020-2031)
5.2 Global Integrase Inhibitors Revenue by Application (2020-2031)
5.2.1 Global Integrase Inhibitors Revenue by Application (2020-2025)
5.2.2 Global Integrase Inhibitors Revenue by Application (2026-2031)
5.2.3 Global Integrase Inhibitors Revenue Market Share by Application (2020-2031)
5.3 Global Integrase Inhibitors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Integrase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Integrase Inhibitors Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Integrase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Integrase Inhibitors Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Hetero Drugs
6.3.1 Hetero Drugs Company Information
6.3.2 Hetero Drugs Description and Business Overview
6.3.3 Hetero Drugs Integrase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hetero Drugs Integrase Inhibitors Product Portfolio
6.3.5 Hetero Drugs Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Integrase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Integrase Inhibitors Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Company Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Integrase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aurobindo Pharma Integrase Inhibitors Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Integrase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cipla Integrase Inhibitors Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Laurus Labs
6.7.1 Laurus Labs Company Information
6.7.2 Laurus Labs Description and Business Overview
6.7.3 Laurus Labs Integrase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Laurus Labs Integrase Inhibitors Product Portfolio
6.7.5 Laurus Labs Recent Developments/Updates
6.8 Gilead Sciences
6.8.1 Gilead Sciences Company Information
6.8.2 Gilead Sciences Description and Business Overview
6.8.3 Gilead Sciences Integrase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Gilead Sciences Integrase Inhibitors Product Portfolio
6.8.5 Gilead Sciences Recent Developments/Updates
6.9 Micro Labs
6.9.1 Micro Labs Company Information
6.9.2 Micro Labs Description and Business Overview
6.9.3 Micro Labs Integrase Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Micro Labs Integrase Inhibitors Product Portfolio
6.9.5 Micro Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Integrase Inhibitors Industry Chain Analysis
7.2 Integrase Inhibitors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Integrase Inhibitors Production Mode & Process Analysis
7.4 Integrase Inhibitors Sales and Marketing
7.4.1 Integrase Inhibitors Sales Channels
7.4.2 Integrase Inhibitors Distributors
7.5 Integrase Inhibitors Customer Analysis
8 Integrase Inhibitors Market Dynamics
8.1 Integrase Inhibitors Industry Trends
8.2 Integrase Inhibitors Market Drivers
8.3 Integrase Inhibitors Market Challenges
8.4 Integrase Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Integrase Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Integrase Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Integrase Inhibitors Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Integrase Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Integrase Inhibitors Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Integrase Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Integrase Inhibitors Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Integrase Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Integrase Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Integrase Inhibitors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Integrase Inhibitors, Product Type & Application
 Table 12. Global Key Manufacturers of Integrase Inhibitors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Integrase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Integrase Inhibitors as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Integrase Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Integrase Inhibitors Sales by Region (2020-2025) & (K Units)
 Table 18. Global Integrase Inhibitors Sales Market Share by Region (2020-2025)
 Table 19. Global Integrase Inhibitors Sales by Region (2026-2031) & (K Units)
 Table 20. Global Integrase Inhibitors Sales Market Share by Region (2026-2031)
 Table 21. Global Integrase Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Integrase Inhibitors Revenue Market Share by Region (2020-2025)
 Table 23. Global Integrase Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Integrase Inhibitors Revenue Market Share by Region (2026-2031)
 Table 25. North America Integrase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Integrase Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 27. North America Integrase Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 28. North America Integrase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Integrase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Integrase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Integrase Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Integrase Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Integrase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Integrase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Integrase Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Integrase Inhibitors Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Integrase Inhibitors Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Integrase Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Integrase Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Integrase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Integrase Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Integrase Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Integrase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Integrase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Integrase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Integrase Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Integrase Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Integrase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Integrase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Integrase Inhibitors Sales (K Units) by Type (2020-2025)
 Table 51. Global Integrase Inhibitors Sales (K Units) by Type (2026-2031)
 Table 52. Global Integrase Inhibitors Sales Market Share by Type (2020-2025)
 Table 53. Global Integrase Inhibitors Sales Market Share by Type (2026-2031)
 Table 54. Global Integrase Inhibitors Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Integrase Inhibitors Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Integrase Inhibitors Revenue Market Share by Type (2020-2025)
 Table 57. Global Integrase Inhibitors Revenue Market Share by Type (2026-2031)
 Table 58. Global Integrase Inhibitors Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Integrase Inhibitors Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Integrase Inhibitors Sales (K Units) by Application (2020-2025)
 Table 61. Global Integrase Inhibitors Sales (K Units) by Application (2026-2031)
 Table 62. Global Integrase Inhibitors Sales Market Share by Application (2020-2025)
 Table 63. Global Integrase Inhibitors Sales Market Share by Application (2026-2031)
 Table 64. Global Integrase Inhibitors Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Integrase Inhibitors Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Integrase Inhibitors Revenue Market Share by Application (2020-2025)
 Table 67. Global Integrase Inhibitors Revenue Market Share by Application (2026-2031)
 Table 68. Global Integrase Inhibitors Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Integrase Inhibitors Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Integrase Inhibitors Product
 Table 74. Merck Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Integrase Inhibitors Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Hetero Drugs Company Information
 Table 81. Hetero Drugs Description and Business Overview
 Table 82. Hetero Drugs Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hetero Drugs Integrase Inhibitors Product
 Table 84. Hetero Drugs Recent Developments/Updates
 Table 85. Mylan Company Information
 Table 86. Mylan Description and Business Overview
 Table 87. Mylan Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mylan Integrase Inhibitors Product
 Table 89. Mylan Recent Developments/Updates
 Table 90. Aurobindo Pharma Company Information
 Table 91. Aurobindo Pharma Description and Business Overview
 Table 92. Aurobindo Pharma Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Aurobindo Pharma Integrase Inhibitors Product
 Table 94. Aurobindo Pharma Recent Developments/Updates
 Table 95. Cipla Company Information
 Table 96. Cipla Description and Business Overview
 Table 97. Cipla Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Cipla Integrase Inhibitors Product
 Table 99. Cipla Recent Developments/Updates
 Table 100. Laurus Labs Company Information
 Table 101. Laurus Labs Description and Business Overview
 Table 102. Laurus Labs Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Laurus Labs Integrase Inhibitors Product
 Table 104. Laurus Labs Recent Developments/Updates
 Table 105. Gilead Sciences Company Information
 Table 106. Gilead Sciences Description and Business Overview
 Table 107. Gilead Sciences Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Gilead Sciences Integrase Inhibitors Product
 Table 109. Gilead Sciences Recent Developments/Updates
 Table 110. Micro Labs Company Information
 Table 111. Micro Labs Description and Business Overview
 Table 112. Micro Labs Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Micro Labs Integrase Inhibitors Product
 Table 114. Micro Labs Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Integrase Inhibitors Distributors List
 Table 118. Integrase Inhibitors Customers List
 Table 119. Integrase Inhibitors Market Trends
 Table 120. Integrase Inhibitors Market Drivers
 Table 121. Integrase Inhibitors Market Challenges
 Table 122. Integrase Inhibitors Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Integrase Inhibitors
 Figure 2. Global Integrase Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Integrase Inhibitors Market Share by Type: 2024 & 2031
 Figure 4. Raltegravir Product Picture
 Figure 5. Dolutegravir Product Picture
 Figure 6. Elvitegravir Product Picture
 Figure 7. Bictegravir Product Picture
 Figure 8. Global Integrase Inhibitors Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Integrase Inhibitors Market Share by Application: 2024 & 2031
 Figure 10. Clinic
 Figure 11. Hospital
 Figure 12. Global Integrase Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Integrase Inhibitors Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Integrase Inhibitors Sales (2020-2031) & (K Units)
 Figure 15. Global Integrase Inhibitors Average Price (US$/Unit) & (2020-2031)
 Figure 16. Integrase Inhibitors Report Years Considered
 Figure 17. Integrase Inhibitors Sales Share by Manufacturers in 2024
 Figure 18. Global Integrase Inhibitors Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Integrase Inhibitors Players: Market Share by Revenue in Integrase Inhibitors in 2024
 Figure 20. Integrase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Integrase Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Integrase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 23. North America Integrase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Integrase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 27. Europe Integrase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Integrase Inhibitors Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Integrase Inhibitors Revenue Market Share by Region (2020-2031)
 Figure 35. China Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Integrase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Integrase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Integrase Inhibitors Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Integrase Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Integrase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Integrase Inhibitors by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Integrase Inhibitors by Type (2020-2031)
 Figure 57. Global Integrase Inhibitors Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Integrase Inhibitors by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Integrase Inhibitors by Application (2020-2031)
 Figure 60. Global Integrase Inhibitors Price (US$/Unit) by Application (2020-2031)
 Figure 61. Integrase Inhibitors Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS